SCHEMBL22177230

SCHEMBL22177230

c1ccc(-c2ccc(-c3nc(-c4ccccc4)nc(-c4cccc5oc6ccc(-c7cccc(-c8nc9ccccc9s8)c7)cc6c45)n3)cc2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 9/20 0.44
▸ RAB9A P51151 7/20 0.44
▸ KDM4E B2RXH2 5/20 0.44
▸ NFKB1 P19838 4/20 0.44
▸ NFKB2 Q00653 4/20 0.44
▸ RELA Q04206 4/20 0.44
▸ ALDH1A1 P00352 4/20 0.44
▸ SMN1; SMN2 Q16637 4/20 0.44
▸ NPC1 O15118 4/20 0.44
▸ POLB P06746 3/20 0.44
▸ LMNA P02545 3/20 0.44
▸ TP53 P04637 2/20 0.44
▸ HSD17B10 Q99714 2/20 0.44
▸ MEN1 O00255 2/20 0.44
▸ KMT2A Q03164 2/20 0.44
▸ HPGD P15428 2/20 0.43
▸ THRB P10828 2/20 0.43
▸ CTDSP1 Q9GZU7 2/20 0.43
▸ APP P05067 4/20 0.42
▸ TDP1 Q9NUW8 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22177964 1.00 MAPT (0.44) MAPTRAB9AKDM4ENFKB1NFKB2
SCHEMBL22177150 1.00 MAPT (0.44) MAPTRAB9AKDM4ENFKB1NFKB2
SCHEMBL22177228 1.00 MAPT (0.44) MAPTRAB9AKDM4ENFKB1NFKB2
SCHEMBL22177227 0.99 MAPT (0.44) MAPTRAB9AKDM4ENFKB1NFKB2
SCHEMBL22177151 0.98 MAPT (0.45) MAPTRAB9AKDM4ENFKB1NFKB2
SCHEMBL22177966 0.98 MAPT (0.45) MAPTRAB9AKDM4ENFKB1NFKB2
SCHEMBL22177898 0.97 MAPT (0.44) MAPTRAB9AKDM4ENFKB1NFKB2
SCHEMBL22177859 0.97 MAPT (0.43) MAPTRAB9AKDM4ENFKB1NFKB2
SCHEMBL22178378 0.97 APP (0.44) MAPTRAB9AKDM4ENFKB1NFKB2
SCHEMBL22178375 0.97 APP (0.44) MAPTRAB9AKDM4ENFKB1NFKB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11518769-B2 Heterocyclic compounds and organic light emitting device using the same LG CHEM, LTD. (KR) 2022-12-06 — — US disclosed
US-20200207754-A1 NOVEL HETEROCYCLIC COMPOUNDS AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME LG CHEM, LTD. (KR) 2020-07-02 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200207754-A1 NOVEL HETEROCYCLIC COMPOUNDS AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME CRY1, CRY2, CYP1A1 MAPT 1997/4885RAB9A 2411/4885KDM4E 2374/4885
US-11518769-B2 Heterocyclic compounds and organic light emitting device using the same CRY1, CYP1A1, CRY2 MAPT 1660/4885RAB9A 2545/4885KDM4E 3498/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback